98 related articles for article (PubMed ID: 6436119)
21. [Evaluation of thermostability of lyophilized BCG vaccines by using an accelerated thermal degradation test].
Janaszek W
Med Dosw Mikrobiol; 1991; 43(1-2):43-9. PubMed ID: 1784137
[TBL] [Abstract][Full Text] [Related]
22. [Molecular characterization of Brucella abortus strain 19 and its application for controlling biologics].
Pavan ME; Nicola A; Grimoldi F; Cairó F
Rev Argent Microbiol; 2005; 37(3):122-5. PubMed ID: 16323658
[TBL] [Abstract][Full Text] [Related]
23. [Trials of the use of live vaccines against brucellosis and listeriosis in farm animals].
Titov VV
Arch Exp Veterinarmed; 1980; 34(1):115-8. PubMed ID: 6774688
[TBL] [Abstract][Full Text] [Related]
24. [Use of the B19 strain in the prevention of bovine brucellosis in northern Cameroon. Study of effect of the dose on seroconversion rate and duration in female zebu].
Martrenchar A; Bouchel D; Njanpop BM; Yaya A
Rev Elev Med Vet Pays Trop; 1995; 48(1):37-40. PubMed ID: 7569229
[TBL] [Abstract][Full Text] [Related]
25. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51.
Ashford DA; di Pietra J; Lingappa J; Woods C; Noll H; Neville B; Weyant R; Bragg SL; Spiegel RA; Tappero J; Perkins BA
Vaccine; 2004 Sep; 22(25-26):3435-9. PubMed ID: 15308369
[TBL] [Abstract][Full Text] [Related]
26. Application of pulsed-field gel electrophoresis for differentiation of vaccine strain RB51 from field isolates of Brucella abortus from cattle, bison, and elk.
Jensen AE; Cheville NF; Ewalt DR; Payeur JB; Thoen CO
Am J Vet Res; 1995 Mar; 56(3):308-12. PubMed ID: 7771697
[TBL] [Abstract][Full Text] [Related]
27. Reduced cerebral infection of Neospora caninum in BALB/c mice vaccinated with recombinant Brucella abortus RB51 strains expressing N. caninum SRS2 and GRA7 proteins.
Vemulapalli R; Sanakkayala N; Gulani J; Schurig GG; Boyle SM; Lindsay DS; Sriranganathan N
Vet Parasitol; 2007 Sep; 148(3-4):219-30. PubMed ID: 17651896
[TBL] [Abstract][Full Text] [Related]
28. [Effect of Brucella abortus on growth of ovarian granulosa cell carcinoma].
Litvinkova NP; Trubcheninova LP; Baryshnikov AIu
Biull Eksp Biol Med; 1980 Nov; 90(11):600-2. PubMed ID: 6778536
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of cell-mediated immune responses and bacterial clearance in 6-10 months old water buffalo (Bubalus bubalis) experimentally vaccinated with four dosages of commercial Brucella abortus strain RB51 vaccine.
Diptee MD; Adesiyun AA; Asgarali Z; Campbell M; Fosgate GT
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):209-20. PubMed ID: 15963819
[TBL] [Abstract][Full Text] [Related]
30. Brucella abortus strain RB51 leucine auxotroph as an environmentally safe vaccine for plasmid maintenance and antigen overexpression.
Rajasekaran P; Seleem MN; Contreras A; Purwantini E; Schurig GG; Sriranganathan N; Boyle SM
Appl Environ Microbiol; 2008 Nov; 74(22):7051-5. PubMed ID: 18836016
[TBL] [Abstract][Full Text] [Related]
31. Increased resistance to tumor graft in mice infected by vaccinal strains of Brucella abortus.
Dazord L; le Garrec Y; Bonnier M; Toujas L
Recent Results Cancer Res; 1980; 75():92-9. PubMed ID: 6785847
[TBL] [Abstract][Full Text] [Related]
32. Post-exposure serological and bacteriological responses of water buffalo (Bubalus bubalis) to Brucella abortus biovar 1 following vaccination with Brucella abortus strain RB51.
Diptee MD; Asgarali Z; Campbell M; Fosgate G; Adesiyun AA
Rev Sci Tech; 2007 Dec; 26(3):669-78. PubMed ID: 18293615
[TBL] [Abstract][Full Text] [Related]
33. Live RB51 vaccine lyophilized hydrogel formulations with increased shelf life for practical ballistic delivery.
Falconer JL; Christie RJ; Pollard EJ; Olsen SC; Grainger DW
Int J Pharm; 2016 Feb; 498(1-2):187-94. PubMed ID: 26705151
[TBL] [Abstract][Full Text] [Related]
34. Human exposure to Brucella abortus strain RB51--Kansas, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(9):172-5. PubMed ID: 9518281
[TBL] [Abstract][Full Text] [Related]
35. Venezuelan field trials of vaccines against brucellosis in swine.
Lord VR; Cherwonogrodzky JW; Schurig GG; Lord RD; Marcano MJ; Meléndez GE
Am J Vet Res; 1998 May; 59(5):546-51. PubMed ID: 9582954
[TBL] [Abstract][Full Text] [Related]
36. Stability of yellow fever vaccine.
Monath TP
Dev Biol Stand; 1996; 87():219-25. PubMed ID: 8854020
[TBL] [Abstract][Full Text] [Related]
37. [Selection of diluents suitable for freeze-dried living vaccines of Brucella abortus Buck 19 and Erysipelothrix insidiosa].
Boden W
Monatsh Veterinarmed; 1967 May; 22(9):382-7. PubMed ID: 4969780
[No Abstract] [Full Text] [Related]
38. Evaluation of Brucella abortus DNA and RNA vaccines expressing Cu-Zn superoxide dismutase (SOD) gene in cattle.
Sáez D; Guzmán I; Andrews E; Cabrera A; Oñate A
Vet Microbiol; 2008 Jun; 129(3-4):396-403. PubMed ID: 18164561
[TBL] [Abstract][Full Text] [Related]
39. [Preservation of lyophilized Brucella melitensis Rev. 1 vaccine].
García Carrillo C
Rev Latinoam Microbiol; 1977; 19(1):17-22. PubMed ID: 279055
[No Abstract] [Full Text] [Related]
40. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence.
Lord VR; Schurig GG; Cherwonogrodzky JW; Marcano MJ; Melendez GE
Am J Vet Res; 1998 Aug; 59(8):1016-20. PubMed ID: 9706206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
